The inflammatory cytokine IL-17A, for example, binds to breast cancer cells and activates oncogenic ERK and NF-κB pathways, and can bind to fibroblasts and activate NF-κB and STAT3 pathways leading to production of IL-6 and G-CSF. Here, NFKB1 is linked to breast carcinoma.